258 related articles for article (PubMed ID: 36000664)
1. Utility of MRI-Directed Contrast-Enhanced Mammography for Biopsy Planning for Suspicious MRI-Detected Breast Lesions.
Nida BA; Rooney TB; Miller MM
AJR Am J Roentgenol; 2023 Feb; 220(2):202-211. PubMed ID: 36000664
[No Abstract] [Full Text] [Related]
2. Utility of Targeted Ultrasound to Predict Malignancy Among Lesions Detected on Contrast-Enhanced Digital Mammography.
Coffey K; Sung J; Comstock C; Askin G; Jochelson MS; Morris EA; D'Alessio D
AJR Am J Roentgenol; 2021 Sep; 217(3):595-604. PubMed ID: 33025811
[No Abstract] [Full Text] [Related]
3. Contrast-enhanced ultrasound-guided biopsy of suspicious breast lesions on contrast-enhanced mammography and contrast-enhanced MRI: a case series.
Huang PY; Tsai MY; Huang JS; Lin PY; Chou CP
J Med Ultrason (2001); 2023 Oct; 50(4):521-529. PubMed ID: 37493921
[TBL] [Abstract][Full Text] [Related]
4. MRI only detected lesions: Can contrast enhanced mammography guided biopsy be an alternative method: Initial clinical findings.
Aribal E; Guldogan N; Seker ME; Yilmaz E; Turk EB
Eur J Radiol; 2024 Apr; 173():111373. PubMed ID: 38364588
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of MRI-directed ultrasound and subsequent ultrasound-guided biopsy for suspicious breast MRI findings.
Chikarmane SA; Jin B; Giess CS
Clin Radiol; 2020 Mar; 75(3):185-193. PubMed ID: 31767141
[TBL] [Abstract][Full Text] [Related]
6. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced mammography-guided biopsy: technical feasibility and first outcomes.
Alcantara R; Posso M; Pitarch M; Arenas N; Ejarque B; Iotti V; Besutti G
Eur Radiol; 2023 Jan; 33(1):417-428. PubMed ID: 35895121
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging.
Taylor DB; Burrows S; Saunders CM; Parizel PM; Ives A
Eur Radiol Exp; 2023 Feb; 7(1):8. PubMed ID: 36781808
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced mammography for the assessment of screening recalls: a two-centre study.
Cozzi A; Schiaffino S; Fanizza M; Magni V; Menicagli L; Monaco CG; Benedek A; Spinelli D; Di Leo G; Di Giulio G; Sardanelli F
Eur Radiol; 2022 Nov; 32(11):7388-7399. PubMed ID: 35648209
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Contrast-Enhanced Mammography and Development of Flowchart for BI-RADS Classification of Breast Lesions.
Klarić K; Šribar A; Budisavljević A; Labinac L; Valković Zujić P
Diagnostics (Basel); 2023 Jun; 13(11):. PubMed ID: 37296810
[TBL] [Abstract][Full Text] [Related]
12. Short-term follow-up of contrast-enhanced mammography lesions after negative breast MRI in women with elevated breast cancer risk.
Coffey K; Dixon LB; Sevilimedu V; Jochelson MS; Sung JS
Eur J Radiol; 2023 Nov; 168():111097. PubMed ID: 37738835
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of 9G MRI-guided vacuum-assisted breast biopsy: results of 293 single-center procedures and underestimation rate of high-risk lesions over 12 years.
Rescinito G; Brunetti N; Garlaschi A; Tosto S; Gristina L; Conti B; Pieroni D; Calabrese M; Tagliafico AS
Radiol Med; 2024 May; 129(5):767-775. PubMed ID: 38512628
[TBL] [Abstract][Full Text] [Related]
14. Role of contrast-enhanced mammography in the preoperative detection of ductal carcinoma in situ of the breasts: a comparison with low-energy image and magnetic resonance imaging.
Wang L; Wang P; Shao H; Li J; Yang Q
Eur Radiol; 2024 May; 34(5):3342-3351. PubMed ID: 37853174
[TBL] [Abstract][Full Text] [Related]
15. Comparative Performance of Contrast-enhanced Mammography, Abbreviated Breast MRI, and Standard Breast MRI for Breast Cancer Screening.
Lawson MB; Partridge SC; Hippe DS; Rahbar H; Lam DL; Lee CI; Lowry KP; Scheel JR; Parsian S; Li I; Biswas D; Bryant ML; Lee JM
Radiology; 2023 Aug; 308(2):e230576. PubMed ID: 37581498
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Performance in Diagnosis and Characterization of Breast Lesions: Contrast-Enhanced Mammography Versus Breast Magnetic Resonance Imaging.
Açar ÇR; Orguc S
Clin Breast Cancer; 2024 Apr; ():. PubMed ID: 38777678
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
Hogan MP; Horvat JV; Ross DS; Sevilimedu V; Jochelson MS; Kirstein LJ; Goldfarb SB; Comstock CE; Sung JS
Breast Cancer Res Treat; 2023 Apr; 198(2):349-359. PubMed ID: 36754936
[TBL] [Abstract][Full Text] [Related]
18. The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.
Åhsberg K; Gardfjell A; Nimeus E; Ryden L; Zackrisson S
BMC Cancer; 2021 Oct; 21(1):1115. PubMed ID: 34663236
[TBL] [Abstract][Full Text] [Related]
19. Utility of second-look ultrasound in the management of incidental enhancing lesions detected by breast MR imaging.
Carbognin G; Girardi V; Calciolari C; Brandalise A; Bonetti F; Russo A; Pozzi Mucelli R
Radiol Med; 2010 Dec; 115(8):1234-45. PubMed ID: 20574702
[TBL] [Abstract][Full Text] [Related]
20. Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.
Kim SG; Freed M; Leite APK; Zhang J; Seuss C; Moy L
J Magn Reson Imaging; 2017 May; 45(5):1385-1393. PubMed ID: 27766710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
